human mirna microarray kit (v3 (Agilent technologies)
Structured Review
Human Mirna Microarray Kit (V3, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+mirna+microarray+kit+v3/pm35367938-40-35-42
Average 90 stars, based on 1 article reviews
Images
Related Articles
Fluorescence:Article Title: Myc/miR-378/TOB2/cyclin D1 functional module regulates oncogenic transformation. Article Snippet: .. For GFP-based vectors, fluorescence-activated cell sorting was employed to eliminate non-expressing cells; for pBabe-based vectors, puromycin was added to growth medium at a final concentration of 2mg/ml. FACS:Article Title: Myc/miR-378/TOB2/cyclin D1 functional module regulates oncogenic transformation. Article Snippet: .. For GFP-based vectors, fluorescence-activated cell sorting was employed to eliminate non-expressing cells; for pBabe-based vectors, puromycin was added to growth medium at a final concentration of 2mg/ml. Concentration Assay:Article Title: Myc/miR-378/TOB2/cyclin D1 functional module regulates oncogenic transformation. Article Snippet: .. For GFP-based vectors, fluorescence-activated cell sorting was employed to eliminate non-expressing cells; for pBabe-based vectors, puromycin was added to growth medium at a final concentration of 2mg/ml. Expressing:Article Title: Myc/miR-378/TOB2/cyclin D1 functional module regulates oncogenic transformation. Article Snippet: .. For GFP-based vectors, fluorescence-activated cell sorting was employed to eliminate non-expressing cells; for pBabe-based vectors, puromycin was added to growth medium at a final concentration of 2mg/ml. Microarray:Article Title: Myc/miR-378/TOB2/cyclin D1 functional module regulates oncogenic transformation. Article Snippet: .. For GFP-based vectors, fluorescence-activated cell sorting was employed to eliminate non-expressing cells; for pBabe-based vectors, puromycin was added to growth medium at a final concentration of 2mg/ml. |
